Expand VTRS Menu
VTRS MENU

VTRS Latest Press Releases

-- February 3, 2026 --

Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026 PRNewswire 4:34 PM
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026 Globe Newswire 10:00 AM
Viatris Appoints Matthew J. Maletta as Chief Legal Officer PRNewswire 8:30 AM

-- January 20, 2026 --

Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa (Sotagliflozin) for the Treatment of Heart Failure PRNewswire 6:59 AM

-- January 8, 2026 --

Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer PRNewswire 9:05 AM

-- January 6, 2026 --

Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration Globe Newswire 9:00 AM

-- December 18, 2025 --

Viatris Provides Pipeline Update on Four Regulatory Milestones PRNewswire 6:59 AM

-- December 17, 2025 --

Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference PRNewswire 6:59 AM

-- December 6, 2025 --

Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited PRNewswire 9:00 AM

-- December 1, 2025 --

Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration Globe Newswire 9:00 AM

-- November 24, 2025 --

Viatris to Participate in Upcoming Investor Conferences PRNewswire 8:00 AM

-- November 20, 2025 --

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates Globe Newswire 7:30 AM

-- November 13, 2025 --

Viatris Recognized as One of the Fortune World's Best Workplaces in 2025 PRNewswire 8:00 AM

-- November 6, 2025 --

Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance PRNewswire 6:59 AM

-- November 4, 2025 --

Viatris Announces Quarterly Dividend PRNewswire 6:59 AM

-- October 28, 2025 --

Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections Business Wire 8:00 AM

-- October 15, 2025 --

Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia in Japan and Certain Other Markets in the Asia-Pacific Region PRNewswire 4:30 PM

-- October 13, 2025 --

Viatris to Participate in Upcoming Investor Conferences PRNewswire 6:59 AM

-- October 8, 2025 --

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row PRNewswire 11:00 AM

-- October 1, 2025 --

Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025 PRNewswire 9:03 AM

-- September 17, 2025 --

Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection Globe Newswire 10:00 AM
Market Data Delayed 15 Minutes